Literature DB >> 1709095

Variable deletion of exon 9 coding sequences in cystic fibrosis transmembrane conductance regulator gene mRNA transcripts in normal bronchial epithelium.

C S Chu1, B C Trapnell, J J Murtagh, J Moss, W Dalemans, S Jallat, A Mercenier, A Pavirani, J P Lecocq, G R Cutting.   

Abstract

The predicted protein domains coded by exons 9-12 and 19-23 of the 27 exon cystic fibrosis transmembrane conductance regulator (CFTR) gene contain two putative nucleotide-binding fold regions. Analysis of CFTR mRNA transcripts in freshly isolated bronchial epithelium from 12 normal adult individuals demonstrated that all had some CFTR mRNA transcripts with exon 9 completely deleted (exon 9- mRNA transcripts). In most (9 of 12), the exon 9- transcripts represented less than or equal to 25% of the total CFTR transcripts. However, in three individuals, the exon 9- transcripts were more abundant, comprising 39, 62 and 66% of all CFTR transcripts. Re-evaluation of the same individuals 2-4 months later showed the same proportions of exon 9- transcripts. Of the 24 CFTR alleles in the 12 individuals, the sequences of the exon-intron junctions relevant to exon 9 deletion (exon 8-intron 8, intron 8-exon 9, exon 9-intron 9, and intron 9-exon 10) were identical except for the intron 8-exon 9 region sequences. Several individuals had varying lengths of a TG repeat in the region between splice branch and splice acceptor consensus sites. Interestingly, one allele in each of the two individuals with 62 and 66% exon 9- transcripts had a TT deletion in the splice acceptor site for exon 9. These observations suggest either the unlikely possibility that sequences in exon 9 are not critical for the functioning of the CFTR or that only a minority of the CFTR mRNA transcripts need to contain exon 9 sequences to produce sufficient amounts of a normal CFTR to maintain a normal clinical phenotype.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1709095      PMCID: PMC452795          DOI: 10.1002/j.1460-2075.1991.tb07655.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  29 in total

1.  Two patients with cystic fibrosis, nonsense mutations in each cystic fibrosis gene, and mild pulmonary disease.

Authors:  G R Cutting; L M Kasch; B J Rosenstein; L C Tsui; H H Kazazian; S E Antonarakis
Journal:  N Engl J Med       Date:  1990-12-13       Impact factor: 91.245

2.  The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508).

Authors:  E Kerem; M Corey; B S Kerem; J Rommens; D Markiewicz; H Levison; L C Tsui; P Durie
Journal:  N Engl J Med       Date:  1990-11-29       Impact factor: 91.245

Review 3.  The P-loop--a common motif in ATP- and GTP-binding proteins.

Authors:  M Saraste; P R Sibbald; A Wittinghofer
Journal:  Trends Biochem Sci       Date:  1990-11       Impact factor: 13.807

4.  Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis.

Authors:  S H Cheng; R J Gregory; J Marshall; S Paul; D W Souza; G A White; C R O'Riordan; A E Smith
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

5.  Cystic fibrosis. Complementary endeavours.

Authors:  K Davies
Journal:  Nature       Date:  1990-11-08       Impact factor: 49.962

6.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

7.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

8.  Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells.

Authors:  D P Rich; M P Anderson; R J Gregory; S H Cheng; S Paul; D M Jefferson; J D McCann; K W Klinger; A E Smith; M J Welsh
Journal:  Nature       Date:  1990-09-27       Impact factor: 49.962

9.  A U-rich tract enhances usage of an alternative 3' splice site in yeast.

Authors:  B Patterson; C Guthrie
Journal:  Cell       Date:  1991-01-11       Impact factor: 41.582

10.  A novel beta thalassemia gene with a single base mutation in the conserved polypyrimidine sequence at the 3' end of IVS 2.

Authors:  C Beldjord; C Lapoumeroulie; J Pagnier; M Benabadji; R Krishnamoorthy; D Labie; A Bank
Journal:  Nucleic Acids Res       Date:  1988-06-10       Impact factor: 16.971

View more
  33 in total

1.  Genomic sequence analysis of Fugu rubripes CFTR and flanking genes in a 60 kb region conserving synteny with 800 kb of human chromosome 7.

Authors:  H Davidson; M S Taylor; A Doherty; A C Boyd; D J Porteous
Journal:  Genome Res       Date:  2000-08       Impact factor: 9.043

2.  Long-range (17.7 kb) allele-specific polymerase chain reaction method for direct haplotyping of R117H and IVS-8 mutations of the cystic fibrosis transmembrane regulator gene.

Authors:  Genevieve Pont-Kingdon; Mohamed Jama; Christine Miller; Alison Millson; Elaine Lyon
Journal:  J Mol Diagn       Date:  2004-08       Impact factor: 5.568

3.  The two small introns of the Drosophila affinidisjuncta Adh gene are required for normal transcription.

Authors:  R W McKenzie; M D Brennan
Journal:  Nucleic Acids Res       Date:  1996-09-15       Impact factor: 16.971

4.  Restoration of R117H CFTR folding and function in human airway cells through combination treatment with VX-809 and VX-770.

Authors:  Martina Gentzsch; Hong Y Ren; Scott A Houck; Nancy L Quinney; Deborah M Cholon; Pattarawut Sopha; Imron G Chaudhry; Jhuma Das; Nikolay V Dokholyan; Scott H Randell; Douglas M Cyr
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-07-08       Impact factor: 5.464

5.  Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus.

Authors:  B G Harvey; P L Leopold; N R Hackett; T M Grasso; P M Williams; A L Tucker; R J Kaner; B Ferris; I Gonda; T D Sweeney; R Ramalingam; I Kovesdi; S Shak; R G Crystal
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

Review 6.  Spectrum of mutations in cystic fibrosis.

Authors:  G R Cutting
Journal:  J Bioenerg Biomembr       Date:  1993-02       Impact factor: 2.945

7.  The CFTR polymorphisms poly-T, TG-repeats and M470V in Chinese males with congenital bilateral absence of the vas deferens.

Authors:  Wu-Hua Ni; Lei Jiang; Qian-Jin Fei; Jian-Yuan Jin; Xu Yang; Xue-Feng Huang
Journal:  Asian J Androl       Date:  2012-07-30       Impact factor: 3.285

8.  Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis.

Authors:  C S Chu; B C Trapnell; S M Curristin; G R Cutting; R G Crystal
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

9.  Omission of exon 12 in cystic fibrosis transmembrane conductance regulator (CFTR) gene transcripts.

Authors:  R Slomski; M Schloesser; L P Berg; M Wagner; V V Kakkar; D N Cooper; J Reiss
Journal:  Hum Genet       Date:  1992-08       Impact factor: 4.132

Review 10.  The cystic fibrosis gene: a molecular genetic perspective.

Authors:  Lap-Chee Tsui; Ruslan Dorfman
Journal:  Cold Spring Harb Perspect Med       Date:  2013-02-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.